4//SEC Filing
Turgeon Joseph W. 4
Accession 0001209191-20-018998
CIK 0000831547other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:34 PM ET
Size
10.7 KB
Accession
0001209191-20-018998
Insider Transaction Report
Form 4
Turgeon Joseph W.
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.001 par value
2020-03-12+282,427→ 697,695 total - Award
Stock Option (Right to Buy)
2020-03-12+450,000→ 450,000 totalExercise: $2.13Exp: 2030-03-12→ Common Stock (450,000 underlying) - Award
Stock Appreciation Right
2020-03-12+600,000→ 600,000 totalExercise: $2.13Exp: 2030-03-12→ Common Stock (600,000 underlying)
Holdings
- 1,538(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of March 12, 2021, 2022 and 2023, respectively.
- [F2]25% of the option shares vested on March 12, 2020. The remaining option shares shall vest in equal amounts of 25% of the total shares underlying the option shares on each anniversary of the grant date over the next three years.
- [F3]25% of the stock appreciation rights vested on March 12, 2020. The remaining stock appreciation rights shall vest in equal amounts of 25% of the total shares underlying the stock appreciation rights on each anniversary of the grant date over the next three years. The stock appreciation rights can be settled in common stock or cash at the election of the Compensation Committee.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001574659
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:34 PM ET
- Size
- 10.7 KB